1. Business

Neuroscience Antibodies and Assays Market 2023-2027

Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

The Neuroscience Antibodies and Assays Market share is expected to increase by USD 1837.68 million from 2022 to 2027, with an accelerated CAGR of 9.44% – according to the recent market study by Technavio. This report also offers a 5-year historic (2017-2021) data projection of market size, segment, and region. The Y-O-Y growth rate of the Neuroscience Antibodies and Assays Market is estimated at 8.95% as of 2023. Moreover, the market is fragmented. Our analysts have conducted an internal and external analysis of vendors to help companies understand the wider business environment as well as the strength and weaknesses of key market players. Our report also forecasts the Bargaining Power of Buyers & Suppliers and the Threat of New Entrants & Rivalry ranging between LOW-MODERATE during the forecast period.

 

Find Analysis of Price Sensitivity, Lifecycle, Customer Purchase Basket, Adoption Rates, and Purchase Criteria Prepared Exclusively by Technavio Research Analysts

 

  • One of the core components of customer landscape is Price Sensitivity – an analysis of which will help companies refine marketing strategies to gain a competitive advantage.   
  • Moreover, this report also provides impact of price sensitivity drivers (purchases are undifferentiated, purchase is a key cost to the buyer, and quality is not important), which are expected to range between LOW-NEUTRAL from 2023-2027.
  • Our report provides extensive information on the customer landscape of the Neuroscience Antibodies and Assays market, involving qualitative and quantitative intelligence.

FOR A DETAILED OVERVIEW OF CUSTOMER LANDSCAPE, REQUEST SAMPLE PAGES

The Neuroscience Antibodies and Assays Market Report Also Offers Information on the Criticality of Inputs, R&D, Capex, Technology, Labor, and Brand of 20 Vendors Listed Below –

  • Abnova Corp.
  • ADx NeuroSciences NV
  • Bio-Rad Laboratories Inc.
  • Biosensis Pty Ltd.
  • BMG LABTECH GmbH
  • Cell Signaling Technology Inc.
  • Chemie Brunschwig AG
  • Elabscience Biotechnology Inc.
  • Enzo Biochem Inc.
  • F. Hoffmann La Roche Ltd.
  • GenScript Biotech Corp.
  • Merck & Co. Inc.
  • NSJ Bioreagents
  • PerkinElmer Inc.
  • Proteintech Group Inc.
  • Rockland Immunochemicals Inc.
  • Santa Cruz Biotechnology Inc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

DOWNLOAD SAMPLE REPORT FOR MORE ACCESS

Chart & Data Table on 5-Year Historic (2017-2021) Market Size, Comparison and Y-O-Y Growth of Neuroscience Antibodies and Assays Industry Segment

  • The market is segmented by Product (Consumables and Instruments) and End-user (Pharmaceutical and Biopharmaceutical Companies, Academic and Research Institutes, and Hospital and Diagnostic Centers).
  • By Product – The consumables segment shows a gradual increase in demand during 2023-2027.
  • A wide range of assay kits, antibodies, and reagents are used in neuroscience assays to provide high-throughput screening of clinical compounds, discover new disease targets, understand the mechanism of action, and develop clinically relevant biomarkers. There are two types of consumables, namely antibodies and assay kits and reagents.
  • The demand for neuroscience antibodies, assay kits, antigens, and reagents has increased significantly owing to the discovery of new potential drug targets, signaling molecules, and structural proteins in the brain. Moreover, the rising importance of neuroscience processes and neurodegenerative diseases research and the wide availability of antibodies, assay kits, and reagents will drive the growth of the consumables segment during the forecast period.

INTERESTED TO PROCURE THE DATA?

DOWNLOAD SAMPLE REPORT

Increasing Incidence Of Neurological Disorders is Notably Driving the Neuroscience Antibodies and Assays Market Growth

Patients with neurological disorders, such as stroke, epilepsy, Parkinson's disease, and brain tumors, have a high risk of developing a disability. These disorders develop due to various factors such as genetic factors, bacterial and viral infections, and the lack of immune response. Parkinson's Disease (PD) is one of the most common neurological diseases affecting the population. According to the Centers for Disease Control and Prevention (CDC), the prevalence of Parkinson's disease rises from 1% to 4% among people aged 60-80 years. Therefore, factors such as the rising prevalence of neurological disorders and the increasing demand for treating such disorders will fuel the growth of the global neuroscience antibodies and assays market during the forecast period.

TO ACCESS THE LATEST DRIVERS, TRENDS, AND CHALLENGES INFLUENCING THE GROWTH OF THIS MARKET, REQUEST SAMPLE REPORT

Chart & Data Table on Historic Market Size (2017-2021), Comparison and Y-O-Y Growth of 11 Countries of Neuroscience Antibodies and Assays Industry

  • The market is segmented by Geography into North America (The US and Canada), Europe (The UK, GermanyFrance, and Rest of Europe), Asia (China and India), and ROW (ArgentinaAustraliaBrazil, and Rest of the World).
  • North America is projected to contribute 46% to market growth by 2027. North America was the most significant contributing region in the global neuroscience antibodies and assays market, primarily owing to the increasing demand for the diagnosis of neurological disorders. For instance, approximately 6.2 million Americans aged 65 years and above had Alzheimer's disease and dementia, as of March 2021. This figure could grow to 13.8 million by 2060. Thus, the growing aging population, the high prevalence of neurological disorders, high healthcare expenditure on treating neurological diseases, and favorable reimbursement policies for neuro-diagnostic procedures are expected to drive regional market growth during the forecast period.
  • The outbreak of COVID-19 increased the demand for neuroscience antibodies and assays in North America. Patients diagnosed with COVID-19 are prone to neurologic complications. Thus, the rise in neurological disorders due to COVID-19 will lead to R&D related to neurological symptoms, which will positively impact the market during the forecast period. Moreover, lockdown restrictions were lifted owing to large-scale vaccination drives by governments in Q4 2020. This, in turn, is expected to drive the growth of the regional market during the forecast period.

FOR MORE INSIGHTS ON THE MARKET SHARE OF VARIOUS REGIONS, VIEW PDF SAMPLE NOW!

Related Reports –

Bispecific Antibodies for Cancer Market by Type and Geography – Forecast and Analysis 2022-2026 – The market share is expected to increase by USD 396.56 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.06%. Furthermore, this report extensively covers market segmentation by type (CD19 or CD3 and CD30 or CD16A) and geography (North AmericaEuropeAsia, and Rest of World (ROW)). To get more exclusive research insights: VIEW SUMMARY OF THE REPORT FOR MORE 

Anti-CD20 Monoclonal Antibodies (mABs) Market by Product and Geography – Forecast and Analysis 2022-2026 – The market share is expected to increase by USD 9.05 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 9.81%. The increased use of combination therapies is one of the key factors driving the market growth. To get more exclusive research insights: VIEW SUMMARY OF THE REPORT FOR MORE

Neuroscience Antibodies And Assays Market Scope

Report Coverage

Details

Page number

120

Base year

2022

Historical year

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 9.44%

Market growth 2023-2027

USD 1837.68 million

Market structure

Fragmented

YoY growth (%)

8.95

Regional analysis

North America, Europe, Asia, and the Rest of the World (ROW)

Performing market contribution

North America at 46%

Key consumer countries

US, Germany, UK, France, and China

Competitive landscape

Leading companies, Competitive Strategies, Consumer engagement scope

Key companies profiled

Abcam plc, Abnova Corp., ADx NeuroSciences NV, Bio-Rad Laboratories Inc., Biosensis Pty Ltd., BMG LABTECH GmbH, Cell Signaling Technology Inc., Chemie Brunschwig AG, Elabscience Biotechnology Inc., Enzo Biochem Inc., F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Merck & Co. Inc., NSJ Bioreagents, PerkinElmer Inc., Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Siemens AG, and Thermo Fisher Scientific Inc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global neuroscience antibodies and assays market 2017 – 2021 
    • Exhibit 18: Historic Market Size – Data Table on Global neuroscience antibodies and assays market 2017 – 2021 ($ million)
  • 4.2 Product Segment Analysis 2017 – 2021 
    • Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
  • 4.3 End-user Segment Analysis 2017 – 2021 
    • Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 – 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 – 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary 
    • Exhibit 23: Five forces analysis – Comparison between2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry 
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition 
    • Exhibit 29: Chart on Market condition – Five forces 2022 and 2027

6 Market Segmentation by Product

  • 6.1 Market segments 
    • Exhibit 30: Chart on Product – Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
  • 6.2 Comparison by Product 
    • Exhibit 32: Chart on Comparison by Product
    • Exhibit 33: Data Table on Comparison by Product
  • 6.3 Consumables – Market size and forecast 2022-2027
    • Exhibit 34: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on Consumables – Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
  • 6.4 Instruments – Market size and forecast 2022-2027
    • Exhibit 38: Chart on Instruments – Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on Instruments – Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on Instruments – Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Instruments – Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Product 
    • Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by End-user

  • 7.1 Market segments 
    • Exhibit 43: Chart on End-user – Market share 2022-2027 (%)
    • Exhibit 44: Data Table on End-user – Market share 2022-2027 (%)
  • 7.2 Comparison by End-user 
    • Exhibit 45: Chart on Comparison by End-user
    • Exhibit 46: Data Table on Comparison by End-user
  • 7.3 Pharmaceutical and biopharmaceutical companies – Market size and forecast 2022-2027 
    • Exhibit 47: Chart on Pharmaceutical and biopharmaceutical companies – Market size and forecast 2022-2027 ($ million)
    • Exhibit 48: Data Table on Pharmaceutical and biopharmaceutical companies – Market size and forecast 2022-2027 ($ million)
    • Exhibit 49: Chart on Pharmaceutical and biopharmaceutical companies – Year-over-year growth 2022-2027 (%)
    • Exhibit 50: Data Table on Pharmaceutical and biopharmaceutical companies – Year-over-year growth 2022-2027 (%)
  • 7.4 Academic and research institutes – Market size and forecast 2022-2027 
    • Exhibit 51: Chart on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
    • Exhibit 52: Data Table on Academic and research institutes – Market size and forecast 2022-2027 ($ million)
    • Exhibit 53: Chart on Academic and research institutes – Year-over-year growth 2022-2027 (%)
    • Exhibit 54: Data Table on Academic and research institutes – Year-over-year growth 2022-2027 (%)
  • 7.5 Hospital and diagnostic centers – Market size and forecast 2022-2027 
    • Exhibit 55: Chart on Hospital and diagnostic centers – Market size and forecast 2022-2027 ($ million)
    • Exhibit 56: Data Table on Hospital and diagnostic centers – Market size and forecast 2022-2027 ($ million)
    • Exhibit 57: Chart on Hospital and diagnostic centers – Year-over-year growth 2022-2027 (%)
    • Exhibit 58: Data Table on Hospital and diagnostic centers – Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by End-user 
    • Exhibit 59: Market opportunity by End-user ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview 
    • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation 
    • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 63: Chart on Geographic comparison
    • Exhibit 64: Data Table on Geographic comparison
  • 9.3 North America – Market size and forecast 2022-2027
    • Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
    • Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
    • Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
    • Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
  • 9.4 Europe – Market size and forecast 2022-2027
    • Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
    • Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
    • Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
    • Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
  • 9.5 Asia – Market size and forecast 2022-2027
    • Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
    • Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
    • Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
    • Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
    • Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
    • Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
    • Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
    • Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
  • 9.7 US – Market size and forecast 2022-2027
    • Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
    • Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
    • Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
  • 9.8 Germany – Market size and forecast 2022-2027
    • Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
    • Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
    • Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
  • 9.9 China – Market size and forecast 2022-2027
    • Exhibit 89: Chart on China – Market size and forecast 2022-2027 ($ million)
    • Exhibit 90: Data Table on China – Market size and forecast 2022-2027 ($ million)
    • Exhibit 91: Chart on China – Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on China – Year-over-year growth 2022-2027 (%)
  • 9.10 UK – Market size and forecast 2022-2027
    • Exhibit 93: Chart on UK – Market size and forecast 2022-2027 ($ million)
    • Exhibit 94: Data Table on UK – Market size and forecast 2022-2027 ($ million)
    • Exhibit 95: Chart on UK – Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on UK – Year-over-year growth 2022-2027 (%)
  • 9.11 France – Market size and forecast 2022-2027
    • Exhibit 97: Chart on France – Market size and forecast 2022-2027 ($ million)
    • Exhibit 98: Data Table on France – Market size and forecast 2022-2027 ($ million)
    • Exhibit 99: Chart on France – Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on France – Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography 
    • Exhibit 101: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 102: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape 
    • Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption 
    • Exhibit 104: Overview on factors of disruption
  • 11.4 Industry risks 
    • Exhibit 105: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered 
    • Exhibit 106: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 107: Matrix on vendor position and classification
  • 12.3 Abcam plc 
    • Exhibit 108: Abcam plc – Overview
    • Exhibit 109: Abcam plc – Product / Service
    • Exhibit 110: Abcam plc – Key news
    • Exhibit 111: Abcam plc – Key offerings
  • 12.4 Abnova Corp. 
    • Exhibit 112: Abnova Corp. – Overview
    • Exhibit 113: Abnova Corp. – Product / Service
    • Exhibit 114: Abnova Corp. – Key offerings
  • 12.5 ADx NeuroSciences NV 
    • Exhibit 115: ADx NeuroSciences NV – Overview
    • Exhibit 116: ADx NeuroSciences NV – Product / Service
    • Exhibit 117: ADx NeuroSciences NV – Key offerings
  • 12.6 Bio Rad Laboratories Inc. 
    • Exhibit 118: Bio Rad Laboratories Inc. – Overview
    • Exhibit 119: Bio Rad Laboratories Inc. – Business segments
    • Exhibit 120: Bio Rad Laboratories Inc. – Key news
    • Exhibit 121: Bio Rad Laboratories Inc. – Key offerings
    • Exhibit 122: Bio Rad Laboratories Inc. – Segment focus
  • 12.7 BMG LABTECH GmbH 
    • Exhibit 123: BMG LABTECH GmbH – Overview
    • Exhibit 124: BMG LABTECH GmbH – Product / Service
    • Exhibit 125: BMG LABTECH GmbH – Key offerings
  • 12.8 Cell Signaling Technology Inc. 
    • Exhibit 126: Cell Signaling Technology Inc. – Overview
    • Exhibit 127: Cell Signaling Technology Inc. – Product / Service
    • Exhibit 128: Cell Signaling Technology Inc. – Key offerings
  • 12.9 Chemie Brunschwig AG 
    • Exhibit 129: Chemie Brunschwig AG – Overview
    • Exhibit 130: Chemie Brunschwig AG – Product / Service
    • Exhibit 131: Chemie Brunschwig AG – Key offerings
  • 12.10 Elabscience Biotechnology Inc. 
    • Exhibit 132: Elabscience Biotechnology Inc. – Overview
    • Exhibit 133: Elabscience Biotechnology Inc. – Product / Service
    • Exhibit 134: Elabscience Biotechnology Inc. – Key offerings
  • 12.11 F. Hoffmann La Roche Ltd. 
    • Exhibit 135: F. Hoffmann La Roche Ltd. – Overview
    • Exhibit 136: F. Hoffmann La Roche Ltd. – Business segments
    • Exhibit 137: F. Hoffmann La Roche Ltd. – Key news
    • Exhibit 138: F. Hoffmann La Roche Ltd. – Key offerings
    • Exhibit 139: F. Hoffmann La Roche Ltd. – Segment focus
  • 12.12 GenScript Biotech Corp. 
    • Exhibit 140: GenScript Biotech Corp. – Overview
    • Exhibit 141: GenScript Biotech Corp. – Business segments
    • Exhibit 142: GenScript Biotech Corp. – Key news
    • Exhibit 143: GenScript Biotech Corp. – Key offerings
    • Exhibit 144: GenScript Biotech Corp. – Segment focus
  • 12.13 Merck and Co. Inc. 
    • Exhibit 145: Merck and Co. Inc. – Overview
    • Exhibit 146: Merck and Co. Inc. – Business segments
    • Exhibit 147: Merck and Co. Inc. – Key news
    • Exhibit 148: Merck and Co. Inc. – Key offerings
    • Exhibit 149: Merck and Co. Inc. – Segment focus
  • 12.14 PerkinElmer Inc. 
    • Exhibit 150: PerkinElmer Inc. – Overview
    • Exhibit 151: PerkinElmer Inc. – Business segments
    • Exhibit 152: PerkinElmer Inc. – Key news
    • Exhibit 153: PerkinElmer Inc. – Key offerings
    • Exhibit 154: PerkinElmer Inc. – Segment focus
  • 12.15 Rockland Immunochemicals Inc. 
    • Exhibit 155: Rockland Immunochemicals Inc. – Overview
    • Exhibit 156: Rockland Immunochemicals Inc. – Product / Service
    • Exhibit 157: Rockland Immunochemicals Inc. – Key offerings
  • 12.16 Santa Cruz Biotechnology Inc. 
    • Exhibit 158: Santa Cruz Biotechnology Inc. – Overview
    • Exhibit 159: Santa Cruz Biotechnology Inc. – Product / Service
    • Exhibit 160: Santa Cruz Biotechnology Inc. – Key offerings
  • 12.17 Thermo Fisher Scientific Inc. 
    • Exhibit 161: Thermo Fisher Scientific Inc. – Overview
    • Exhibit 162: Thermo Fisher Scientific Inc. – Business segments
    • Exhibit 163: Thermo Fisher Scientific Inc. – Key news
    • Exhibit 164: Thermo Fisher Scientific Inc. – Key offerings
    • Exhibit 165: Thermo Fisher Scientific Inc. – Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 166: Inclusions checklist
    • Exhibit 167: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 168: Currency conversion rates for US$
  • 13.4 Research methodology 
    • Exhibit 169: Research methodology
    • Exhibit 170: Validation techniques employed for market sizing
    • Exhibit 171: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 172: List of abbreviations
About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

SOURCE  Prnewswire

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe